DDL, a provider of package, product, and material testing services, announced on Monday the opening of a new Good Manufacturing Practice (GMP) laboratory for drug-device combination product testing.

This expansion enhances DDL's capacity to support the pharmaceutical, biotech and combination product industries with rigorous, regulatory-compliant testing solutions.

The new FDA-registered 10,600 sq ft GMP lab is located near DDL's headquarters in Eden Prairie, Minnesota. The lab will offer ICH stability testing, functional and mechanical performance testing (ISO 11040 & ISO 11608) and simulated distribution testing to meet the growing demand for high-quality GMP testing for devices such as auto injectors, pre-filled syringes, inhalers and other combination products.

DDL said that its new facility will provide comprehensive testing solutions in accordance with FDA, ISO and other global regulatory standards.